Clinical trials
Phase 1/2 trials in Vietnam
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
27 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 4 |
| 2019 | 4 |
| 2020 | 5 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Unknown status | 8 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Vinmec Research Institute of Stem Cell and Gene Technology | 10 |
| Hanoi Medical University | 4 |
| Oxford University Clinical Research Unit, Vietnam | 2 |
| University of Science Ho Chi Minh City | 2 |
| Van Hanh General Hospital | 2 |
| DNA International Hospital | 1 |
| Hai Yen Eye Care | 1 |
| Nanogen Pharmaceutical Biotechnology Joint Stock Company | 1 |
| Nguyen Ton Ngoc Huynh | 1 |
| Tri Phuoc Biotechnology., JSC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 5 |
| Insulin Resistance | 3 |
| Diabetes Mellitus | 2 |
| Obesity | 2 |
| Pulmonary Disease, Chronic Obstructive | 2 |
| Biliary Atresia | 1 |
| Brain Injuries, Traumatic | 1 |
| COVID-19 | 1 |
| Dengue | 1 |
| Diabetes Mellitus, Type 1 | 1 |
Trials
Showing 76 to 27 of 27. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.